External Validation of a Simple Mortality Risk Prediction Score for Tuberculosis Patients

Authors

Pattama Saisudjarit, Department of Applied Science, School of Sciences, University of Phayao, Phayao, Thailand
Surasak Saokaew, School of Pharmaceutical Sciences, University of Phayao, ThailandFollow
Acharaporn Duangjai, School of Medical Sciences, University of Phayao, Phayao, Thailand
Anurak Prasatkhetragarn, Department of Applied Science, School of Sciences, University of Phayao, Phayao, Thailand
Sukrit Kanchanasurakit, Department of Pharmaceutical Care, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand
Pochamana Phisalprapa, Division of Ambulatory Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

Abstract

Background: Tuberculosis (TB) remains a significant global health issue, contributing to substantial mortality annually; therefore, effective risk stratification is essential for clinical decision-making and optimal resource allocation. This study externally validates a simple mortality prediction score for TB patients that was initially developed by Saisudjarit and colleague in a different population.

Methods: A retrospective cohort study was conducted using TB registry data from four Thai provinces (Nakhon Sawan, Kamphaeng Phet, Chai Nat, and Uthai Thani) collected January 1, 2019–December 31, 2020. Eligible patients were aged ≥ 18 years and had either completed treatment or died during that period. The risk score incorporated three predictors: Charlson Comorbidity Index scores of 1–2 and ≥ 3 points, and the presence of tuberculous meningitis. Model performance was assessed using the area under the receiver operating characteristic curve (AuROC).

Results: Among 4680 patients, the score showed good discrimination (AuROC = 76.3%) and good calibration (Hosmer–Lemeshow χ² = 0.76; P = 0.68). The positive likelihood ratio was 1.02 in the low-risk group (scores ≤ 3) and 5.31 in the high-risk group (scores ≥ 6). Sensitivity/specificity were 1.69%/99.68% in the high-risk group, whereas they were 99.17%/3.21% in the low-risk group. The model correctly predicted mortality in high-risk patients (87.3%) and survival in low-risk patients (87.0%).

Conclusion: This externally validated TB mortality risk score shows acceptable calibration and predictive performance. The risk score can guide clinical risk stratification and treatment planning, thereby improving TB-related outcomes.

Keywords: External validation; Mortality; Risk score; Tuberculosis

Recommended Citation

Saisudjarit P, Saokaew S, Duangjai A, Prasatkhetragarn A, Kanchanasurakit S, Phisalprapa P. External Validation of a Simple Mortality Risk Prediction Score for Tuberculosis Patients. J Health Res. 2026; 40(1):-. DOI: https://doi.org/10.56808/2586-940X.1180

References

[1] World Health Organization [WHO]. Global tuberculosis report 2024. Geneva: WHO; 2024 [cited 2024 Oct 10]. Available from: https://iris.who.int/server/api/core/bitstreams/7292c91e-ffb0-4cef-ac39-0200f06961ea/content.

[2] Ministry of Public Health, Division of Tuberculosis. National tuberculosis control programme guideline, Thailand 2021. Bangkok: Division of Tuberculosis; 2021 [cited 2024 Oct 10]. Available from: https://www.tbthailand.org/download/Manual/NTP%20พิมพ์ ครั ้ง ที ่%202%20Final %20Edit%2022%20Feb%202022(1).pdf.

[3] Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS, Chaisson RE. Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clin Infect Dis 2002;34(6):752—9. https://doi.org/10.1086/338784.

[4] Sterling TR, Zhao Z, Khan A, Chaisson RE, Schluger N, Mangura B, et al. Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. Int J Tuberc Lung Dis 2006;10(5):542—9.

[5] Lefebvre N, Falzon D. Risk factors for death among tuberculosis cases: analysis of European surveillance data. Eur Respir J 2008;31(6):1256—60. https://doi.org/10.1183/0903 1936.00131107.

[6] Amnuaiphon W, Anuwatnonthakate A, Nuyongphak P, Sinthuwatanawibool C, Rujiwongsakorn S, Nakara P, et al. Factors associated with death among HIV-uninfected TB patients in Thailand, 2004-2006. Trop Med Int Health 2009; 14(11):1338—46. https://doi.org/10.1111/j.1365-3156.2009.02376.x.

[7] Horne DJ, Hubbard R, Narita M, Exarchos A, Park DR, Goss CH. Factors associated with mortality in patients with tuberculosis. BMC Infect Dis 2010;10:258. https://doi.org/10.1186/1471-2334-10-258.

[8] Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47(11): 1245—51. https://doi.org/10.1016/0895-4356(94)90129-5.

[9] Prasad R, Sahu D, Sagar S. Risk factors for mortality in tuberculous meningitis: a prospective cohort study in India. J Clin Infect Dis 2018;66(3):503—9.

[10] Saisudjarit P, Saokaew S, Duangjai A, Prasatkhetragarn A, Kanchanasurakit S, Phisalprapa P. Development and validation of clinical prediction score for mortality in tuberculosis patients. Narra J 2025;5(2):e1701. https://doi.org/10. 52225/narra.v5i2.1701.

[11] World Health Organization [WHO]. Implementing the stop TB strategy: a handbook for national tuberculosis control program. Geneva: WHO; 2008.

[12] Zhang S, Tong X, Wang L, Zhang T, Huang J, Wang D, et al. Clinical characteristics and prognostic analysis of patients with pulmonary tuberculosis and type 2 diabetes comorbidity in China: a retrospective analysis. Front Public Health 2021;9:710981. https://doi.org/10.3389/fpubh.2021.710981.

[13] Zou KH, O'Malley AJ, Mauri L. Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation 2007;115(5):654—7. https://doi.org/10.1161/CIRCULATIONAHA.105.594929.

[14] Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: Willey; 2000. [15] Shen X, Deriemer K, Yuan Z, Shen M, Xia Z, Gui X, et al. Deaths among tuberculosis cases in Shanghai, China: who is at risk? BMC Infect Dis 2009;9:95. https://doi.org/10.1186/1471-2334-9-95.

[16] Horita N, Miyazawa N, Yoshiyama T, Sato T, Yamamoto M, Tomaru K, et al. Development and validation of a tuberculosis prognostic score for smear-positive in-patients in Japan. Int J Tuberc Lung Dis 2013;17(1):54—60. https://doi.org/10.5588/ijtld.12.0476.

[17] Bastos HN, Osorio NS, Castro AG, Ramos A, Carvalho T, Meira L, et al. A prediction rule to stratify mortality risk of patients with pulmonary tuberculosis. PLoS One 2016;11(9): e0162797. https://doi.org/10.1371/journal.pone.0162797.

[18] Alobu I, Oshi SN, Oshi DC, Ukwaja KN. Risk factors of treatment default and death among tuberculosis patients in a resource-limited setting. Asian Pac J Trop Med 2014;7(12): 977—84. https://doi.org/10.1016/S1995-7645(14)60172-3.

[19] Atif M, Sulaiman SA, Shafie AA, Ali I, Asif M, Babar ZU. Treatment outcome of new smear positive pulmonary tuberculosis patients in Penang, Malaysia. BMC Infect Dis 2014;14:399. https://doi.org/10.1186/1471-2334-14-399.

[20] Nguyen DT, Graviss EA. Development and validation of a prognostic score to predict tuberculosis mortality. J Infect 2018;77(4):283—90. https://doi.org/10.1016/j.jinf.2018.02.009.

[21] Lai YJ, Liu EY, Wang LM, Morano JP, Wang N, Khoshnood K, et al. Human immunodeficiency virus infection-associated mortality during pulmonary tuberculosis treatment in six provinces of China. Biomed Environ Sci 2015;28(6):421—8. https://doi.org/10.3967/bes2015.059.

[22] Lin CH, Lin CJ, Kuo YW, Wang JY, Hsu CL, Chen JM, et al. Tuberculosis mortality: patient characteristics and causes. BMC Infect Dis 2014;14:5. https://doi.org/10.1186/1471-2334-14-5.

[23] Nguyen DT, Jenkins HE, Graviss EA. Prognostic score to predict mortality during TB treatment in TB/HIV co-infected patients. PLoS One 2018;13(4):e0196022. https://doi.org/10.1371/journal.pone.0196022.